Bioanalytical Tandem Mass Spectrometry Method for Precise Measurement of Tranexamic Acid in Human Plasma With Unveiling Methodological Advancement: Green Assessment With Advanced Metrics
Biomedical Chromatography · 2025-03 · 39 (3)
DOI: 10.1002/bmc.6086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 07.02.2025. Verfasst von Anil Kollapareddy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Koneru Lakshmaiah Education Foundation, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Tranexamic Acid, Tandem Mass Spectrometry, Antifibrinolytic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
For the control of excessive blood loss occurring from major trauma, postpartum bleeding, surgery, or hereditary angioedema, antifibrinolytic compound tranexamic acid (TXM) is highly efficient in controlling blood loss by reversibly binding with on lysine receptor sites. A selective and sensitive method has been developed and validated for the quantitation of TXM in human plasma using high performance liquid chromatography coupled with tandem mass spectrometry (HPLC‐MS/MS). Tranexamic acid‐D2 (TXM‐D2) was used as internal standard (ISTD) to minimize the errors in TXM quantification. TXM quantification was performed with positive polarity mode using a Shimadzu high performance liquid chromatography coupled with AB‐SCIEX API‐4000 tandem mass spectrometer. A Zorbax Eclipse C18 (150 × 4.6 mm, 5 μ) column was used for the TXM quantification, 8‐mM ammonium formate buffer with 0.1% formic acid ionization enhancer was used as a mobile phase‐A, and acetonitrile was used as a mobile phase‐B. (38:62) v/v portion of mobile phases A and B selected to elute the TXM and TXM‐D2 with the flow rate of 0.8 mL/min. An electrospray ionization (ESI) technique was selected for detection of TXM in the human plasma. Linearity was assessed in the concentration range from 75 to 15,000 ng/mL by using least squares of weighting factor linear regression (1/X 2 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Koneru Lakshmaiah Education Foundation, Hyderabad, Telangana, India.
- Department of Chemistry, School of Science, GITAM Deemed to be University, Hyderabad, Telangana, India.
ORCID-Profile: Naresh Konduru, Tanmoy Mondal, Mohan Varkolu, Sreedhar Gundekari
Zitieren
APA
Kollapareddy, A., Sayyad, K., Kowtharapu, L. P., Konduru, N., Mondal, T., Varkolu, M., & Gundekari, S. (2025). Bioanalytical Tandem Mass Spectrometry Method for Precise Measurement of Tranexamic Acid in Human Plasma With Unveiling Methodological Advancement: Green Assessment With Advanced Metrics. Biomedical Chromatography, 39(3). https://doi.org/10.1002/bmc.6086
Vancouver
Kollapareddy A, Sayyad K, Kowtharapu LP, Konduru N, Mondal T, Varkolu M, et al. Bioanalytical Tandem Mass Spectrometry Method for Precise Measurement of Tranexamic Acid in Human Plasma With Unveiling Methodological Advancement: Green Assessment With Advanced Metrics. Biomedical Chromatography. 2025;39(3). doi:10.1002/bmc.6086
BibTeX
@article{Kollapareddy2025,
author = {Kollapareddy, Anil and Sayyad, Kousrali and Kowtharapu, Leela Prasad and Konduru, Naresh and Mondal, Tanmoy and Varkolu, Mohan and Gundekari, Sreedhar},
title = {Bioanalytical Tandem Mass Spectrometry Method for Precise Measurement of Tranexamic Acid in Human Plasma With Unveiling Methodological Advancement: Green Assessment With Advanced Metrics},
journal = {Biomedical Chromatography},
year = {2025},
volume = {39},
number = {3},
doi = {10.1002/bmc.6086}
}
EUVIMED